These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 3744282)
1. Dietary allergy evaluated by PRIST and RAST in inflammatory bowel disease. Brignola C; Miniero R; Campieri M; Bazzocchi G; Vegetti S; Farruggia P; Lanfranchi GA Hepatogastroenterology; 1986 Jun; 33(3):128-30. PubMed ID: 3744282 [TBL] [Abstract][Full Text] [Related]
2. [Increased IgE-type antibody response to food allergens in irritable bowel syndrome and inflammatory bowel diseases]. Mekkel G; Barta Z; Ress Z; Gyimesi E; Sipka S; Zeher M Orv Hetil; 2005 Apr; 146(17):797-802. PubMed ID: 17918636 [TBL] [Abstract][Full Text] [Related]
3. Antineutrophil cytoplasmic antibodies, anti-Saccharomyces cerevisiae antibodies, and specific IgE to food allergens in children with inflammatory bowel diseases. Bartůnková J; Kolárová I; Sedivá A; Hölzelová E Clin Immunol; 2002 Feb; 102(2):162-8. PubMed ID: 11846458 [TBL] [Abstract][Full Text] [Related]
4. Serum IgE levels in patients with inflammatory bowel disease. Levo Y; Shalit M; Wollner S; Fich A Ann Allergy; 1986 Jan; 56(1):85-7. PubMed ID: 3946842 [TBL] [Abstract][Full Text] [Related]
5. Prevalence and diagnostic role of antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Bansi DS; Chapman RW; Fleming KA Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):881-5. PubMed ID: 8889455 [TBL] [Abstract][Full Text] [Related]
6. The circulating common gamma chain (CD132) in inflammatory bowel disease. Nielsen OH; Kirman I; Johnson K; Giedlin M; Ciardelli T Am J Gastroenterol; 1998 Mar; 93(3):323-8. PubMed ID: 9517632 [TBL] [Abstract][Full Text] [Related]
7. Immunoglobulins and IgG subclasses in patients with inflammatory bowel disease. Gouni-Berthold I; Baumeister B; Berthold HK; Schmidt C Hepatogastroenterology; 1999; 46(27):1720-3. PubMed ID: 10430330 [TBL] [Abstract][Full Text] [Related]
8. Dietary antigens in Crohn's disease: antibodies to porcine pancreatic amylase. Suzuki H; Fukuda Y; Koizuka H; Tomita T; Hori K; Suzuki M; O'Morain C Am J Gastroenterol; 2008 Mar; 103(3):656-64. PubMed ID: 18028509 [TBL] [Abstract][Full Text] [Related]
9. IgE in inflammatory bowel disease. Becker SA; Bass DD; Weissglas L; Cohen D Isr J Med Sci; 1983 Dec; 19(12):1105-6. PubMed ID: 6662701 [No Abstract] [Full Text] [Related]
11. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease. Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968 [TBL] [Abstract][Full Text] [Related]
12. [Interest of serologic markers in inflammatory bowel disease. About 105 cases]. Fekih M; Ben Hlima S; Zitouni M; Matri S; Boubaker J; Makni S; Azza F Tunis Med; 2007 Oct; 85(10):821-8. PubMed ID: 18236802 [TBL] [Abstract][Full Text] [Related]
13. IgG oligosaccharide alterations are a novel diagnostic marker for disease activity and the clinical course of inflammatory bowel disease. Shinzaki S; Iijima H; Nakagawa T; Egawa S; Nakajima S; Ishii S; Irie T; Kakiuchi Y; Nishida T; Yasumaru M; Kanto T; Tsujii M; Tsuji S; Mizushima T; Yoshihara H; Kondo A; Miyoshi E; Hayashi N Am J Gastroenterol; 2008 May; 103(5):1173-81. PubMed ID: 18177457 [TBL] [Abstract][Full Text] [Related]
14. Phagocytosis, killing, lymphocyte-mediated antibacterial activity, serum autoantibodies, and plasma endotoxins in inflammatory bowel disease. Caradonna L; Amati L; Lella P; Jirillo E; Caccavo D Am J Gastroenterol; 2000 Jun; 95(6):1495-502. PubMed ID: 10894586 [TBL] [Abstract][Full Text] [Related]
15. Antineutrophil cytoplasmic antibodies in Japanese patients with inflammatory bowel disease: prevalence and recognition of putative antigens. Sugi K; Saitoh O; Matsuse R; Tabata K; Uchida K; Kojima K; Nakagawa K; Tanaka S; Teranishi T; Hirata I; Katsu K Am J Gastroenterol; 1999 May; 94(5):1304-12. PubMed ID: 10235211 [TBL] [Abstract][Full Text] [Related]
16. Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease. Hanai H; Iida T; Takeuchi K; Watanabe F; Yamada M; Kikuyama M; Maruyama Y; Iwaoka Y; Hirayama K; Nagata S; Takai K Am J Gastroenterol; 2008 May; 103(5):1210-6. PubMed ID: 18177452 [TBL] [Abstract][Full Text] [Related]
17. The subpopulations of circulating white blood cells in inflammatory bowel disease. Thayer WR; Charland C; Field CE Gastroenterology; 1976 Sep; 71(3):379-84. PubMed ID: 1084844 [TBL] [Abstract][Full Text] [Related]
18. [Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases]. Mokrowiecka A; Gasiorowska A; Małecka-Panas E Pol Merkur Lekarski; 2004; 17 Suppl 1():22-6. PubMed ID: 15603341 [TBL] [Abstract][Full Text] [Related]